NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Apreo Health

Apreo Health

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://apreohealth.com/

Last Round

Corporate Funding

May 13, 2026

Total Funding Raised

$153M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Apreo Health is a medical device company developing a tissue-sparing treatment for severe emphysema.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

emphysema treatmentCOPD treatmentairway scaffoldmedical devicebronchoscopic implantCOPDinterventional pulmonologyminimally invasive procedurenitinol implanttissue-sparing therapycollateral ventilationlung hyperinflationairway stentFDA breakthrough deviceclinical stage medtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Apreo Health Comps

Public and private peers based on sector, stage, and business model.

Apreo Health comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Apreo Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMay 13, 2026
Series BAug 7, 2025

Key People

Founding team and executive leadership

Martin Mayse

Co-Founder, Chief Scientific Officer, Board Member

Founding Team

Patrick Wu

Chief Technology Officer

Executive Team

Edward Enyeart

Chief Financial Officer

Executive Team

Jonathan Porter

Chief Product Officer

Executive Team

Apreo Health Investors

Notable investors and investment history

Apreo Health investors
InvestorRounds
Bain Capital Life SciencesSeries B
Lightstone VenturesSeries B, Series A
Santé VenturesSeries B, Series A
Norwest Venture PartnersSeries B
Intuitive VenturesSeries B
F-Prime CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 28, 2026

    Grew 33% QoQ, from 24 to 32 employees.

  • Jun 21, 2026

    Monthly visitors increased 137% MoM, reaching 1.9K.

Apreo Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Apreo Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Apreo Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range32
Year Founded2021
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.